Media Center

Latest from the Blogs

  1. January 7, 2021

    New Treatment Arms Opening for Patients in NBTS-Funded GBM AGILE Clinical Trial

    Yesterday, it was announced that the GBM AGILE adaptive clinical trial platform is opening two new treatment arms, with one evaluating Kintara Therapeutics’s chemotherapy, VAL-083, and Kazia Therapeutics’s targeted therapy, paxalisib.  “NBTS has long supported GBM AGILE as a scientifically cutting-edge and more patient-friendly way to develop and evaluate emerging new treatments for patients,” says […]

    Read more | 
  2. December 19, 2020

    4 Big Takeaways From the 2020 Annual Meeting of the Society for Neuro-Oncology

    A move to a virtual platform didn’t diminish the quality of the 2020 Annual Meeting of the Society for Neuro-Oncology (SNO), the yearly gathering of the world’s foremost brain tumor researchers and clinicians. As usual, the National Brain Tumor Society was a proud platinum sponsor of this important conference and deployed our own team of […]

    Read more | 

Media Contacts

If you need additional information, have a specific request, or would like a comment from National Brain Tumor Society, please use the contacts below:

Tom Halkin
Senior Manager of Communications
617 393 2849
thalkin@braintumor.org

Share